Skip to main content
. Author manuscript; available in PMC: 2023 Nov 20.
Published in final edited form as: Ann Rheum Dis. 2020 Oct 8;80(3):286–292. doi: 10.1136/annrheumdis-2020-218282

Table 3.

Comparison of multimorbidity burden between rheumatoid arthritis (RA) and non-RA patients.

Chronic conditionsa Charlson-Deyob RDCI
Mean (SD) Ratio (95% CI) Mean (SD) Ratio (95% CI) Mean (SD) Ratio (95% CI)
Baseline (all patients, n=277,782)
  RA 1.47 (2.00) 1.68 (1.66, 1.70) 0.23 (0.58) 1.32 (1.29, 1.35) 0.54 (0.96) 1.39 (1.37, 1.41)
  Non-RA 0.88 (1.48) Ref 0.18 (0.51) Ref 0.39 (0.82) Ref
With1 year of follow-up (n=226,850)
  RA 2.20 (2.28) 1.66 (1.65, 1.68) 0.37 (0.72) 1.37 (1.35, 1.39) 0.85 (1.15) 1.42 (1.40, 1.44)
  Non-RA 1.33 (1.76) Ref 0.27 (0.63) Ref 0.60 (0.98) Ref

RA and non-RA matched on sex, year of birth, and year of entry into the database

All P < 0.001

a

N=44 chronic conditions

b

Connective tissue disease was not included in scoring

Abbreviations: CI, confidence interval; OR, odds ratio; RA, rheumatoid arthritis; RDCI, Rheumatic Disease Comorbidity Index